IMPACT OF IMMUNE-CHECKPOINT INHIBITORS ON LONG-TERM DISEASE COURSE OF AND DEVELOPMENT OF MICROSCOPIC COLITIS

被引：0
|
作者：
Fredrick, Thomas W.
Ramos, Guilherme P.
Braga Neto, Manuel B.
Kane, Sunanda V.
Faubion, William
Loftus, Edward V.
Pardi, Darrell S.
Raffals, Laura H.
机构：
来源：
GASTROENTEROLOGY | 2021年 / 160卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
242
引用
收藏
页码：S52 / S52
页数：1
相关论文
共 50 条
  • [41] Assessing Long-Term Survival Benefits of Immune Checkpoint Inhibitors Using the Net Survival Benefit
    Peron, Julien
    Lambert, Alexandre
    Munier, Stephane
    Ozenne, Brice
    Giai, Joris
    Roy, Pascal
    Dalle, Stephane
    Machingura, Abigirl
    Maucort-Boulch, Delphine
    Buyse, Marc
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2019, 111 (11): : 1186 - 1191
  • [42] Impact of Bariatric Surgery on the Long-term Disease Course of Inflammatory Bowel Disease
    Braga Neto, Manuel B.
    Gregory, Martin H.
    Ramos, Guilherme P.
    Bazerbachi, Fateh
    Bruining, David H.
    Abu Dayyeh, Barham K.
    Kushnir, Vladimir M.
    Raffals, Laura E.
    Ciorba, Matthew A.
    Loftus, Edward V., Jr.
    Deepak, Parakkal
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (07) : 1089 - 1097
  • [43] Prolonged disease control with local treatments in oligo-acquired resistance to immune-checkpoint inhibitors
    Arasanz, Hugo
    Morilla, Idoia
    Martinez-Aguillo, Maite
    Teijeira, Lucia
    Vera, Ruth
    Alsina, Maria
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (06) : 1332 - 1334
  • [44] Impact of medical students' descriptive evaluations on long-term course development
    Wahlqvist M.
    Skott A.
    Björkelund C.
    Dahlgren G.
    Lonka K.
    Mattsson B.
    BMC Medical Education, 6 (1)
  • [45] Histological disease activity in patients with microscopic colitis is not related to clinical disease activity or long-term prognosis
    Olsen, Laerke Mueller
    Engel, Peter Johan Heiberg
    Goudkade, Danny
    Villanacci, Vincenzo
    Thagaard, Jeppe
    Walbech, Julie Sparholt
    Bohr, Johan
    Kupcinskas, Juozas
    Verhaegh, Bas
    Munch, Andreas
    Guagnozzi, Danila
    Fernandez-Banares, Fernando
    Munck, Lars Kristian
    Fiehn, Anne-Marie Kanstrup
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (01) : 43 - 52
  • [46] Factors associated with long-term clinical outcome in microscopic colitis
    Miyatani, Yusuke
    Komaki, Yuga
    Komaki, Fukiko
    Micic, Dejan
    Keyashian, Kian
    Sakuraba, Atsushi
    ANNALS OF MEDICINE, 2024, 56 (01)
  • [47] Immune Checkpoint Inhibitor Related Colitis (ICI-Colitis) in Patients With Preexisting Inflammatory Bowel Disease or Microscopic Colitis
    Sleiman, Joseph
    Shah, Ravi
    Wei, Wei
    Funchain, Pauline
    Philpott, Jessica
    Simons-Linares, Roberto
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S393 - S393
  • [48] Long-term remission of small cell lung cancer after reactivation of tuberculosis following immune-checkpoint blockade: A case report
    Sirgiovanni, Mattia
    Hinterleitner, Clemens
    Horger, Marius
    Atique, Naushad Bijoy
    Lauer, Ulrich M.
    Zender, Lars
    Hinterleitner, Martina
    THORACIC CANCER, 2021, 12 (05) : 699 - 702
  • [49] Impact of Lymphopenia on Survival Following Stereotactic Radiosurgery and Immune-Checkpoint Inhibitors Among Patients with Brain Metastases
    Benitez, C. M.
    Koenig, J. L.
    Sborov, K.
    Gibbs, I. C.
    Gensheimer, M. F.
    Soltys, S. G.
    Pollom, E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S144 - S144
  • [50] Clinical predictors of long-term responses to immune checkpoint inhibitors (ICI) in a multi-tumor cohort
    Albarran Fernandez, V.
    Guerrero, P.
    Gonzalez Merino, C.
    Garcia de Quevedo Suero, C.
    Chamorro-Perez, J.
    Rosero Rodriguez, D. I.
    Barrill Corpa, A. M.
    Sotoca-Rubio, P.
    Alia Navarro, V.
    Perez de Aguado, P.
    Calvo, J. C.
    Moreno, J.
    San Roman Gil, M. V.
    Alvarez Ballesteros, P.
    Cortes Salgado, A.
    Olmedo Garcia, M. E.
    Gomez Rueda, A.
    Garrido Lopez, P.
    Soria Rivas, A.
    Gajate, P.
    ANNALS OF ONCOLOGY, 2024, 35 : S1090 - S1090
12345